Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1971 Apr;41(4):661–673. doi: 10.1111/j.1476-5381.1971.tb07074.x

Metabolism of cardiac glycosides studied in the isolated perfused guinea-pig liver

K-D Kolenda, H Lüllmann, T Peters
PMCID: PMC1702767  PMID: 5579464

Abstract

1. Metabolic degradation of tritiated ouabain, digoxin, and digitoxin has been investigated quantitatively using the isolated perfused guinea-pig liver. The cardiac glycosides and their metabolites have been extracted from the plasma, liver, and bile by different solvents and identified as far as possible by radio-chromatographic analysis.

2. The total metabolic activity in the experimental system was localized in the liver.

3. The hydrophilic glycoside ouabain could not penetrate into the metabolically active compartment of the liver and was, therefore, not degraded. The more lipophilic compound digitoxin, however, was completely degraded due to its high affinity for the metabolically active sites. The unchanged digitoxin cannot enter the aqueous bile fluid in contrast to its more hydrophilic metabolites.

4. The only detectable metabolic degradation of digoxin was a conjugation with glucuronic and/or sulphuric acid, but a cleavage of sugar molecules seemed not to occur.

5. In the case of digitoxin the metabolic processes are more complicated: sugar cleavage, conjugation, and C-12 hydroxylation take place simultaneously. An immediate hydroxylation of digitoxin leading to digoxin was not observed. After administration of digitoxin conjugation products as well as digoxigenin-bis-and digoxigenin-mono-digitoxosides were present in each of the compartments investigated, but the digitoxosides of digitoxigenin were intermediates in concentrations too low to be determined indicating a very high rate of conjugation and/or C-12 hydroxylation as compared with the cleavage of the digitoxoses.

6. A scheme for the metabolic pathways of the cardiac glycosides based on experimental results is presented. The metabolic behaviour of each of the three compounds involved is closely related to their physicochemical properties, especially the lipid solubility.

Full text

PDF
661

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHLEY J. J., BROWN B. T., OKITA G. T., WRIGHT S. E. The metabolites of cardiac glycosides in human urine. J Biol Chem. 1958 May;232(1):315–322. [PubMed] [Google Scholar]
  2. Abel RM LUCHI R. J., Peskin G. W., Conn H. L., Jr, Miller L. D. Metabolism of digoxin: role of the liver in tritiated digoxin degradation. J Pharmacol Exp Ther. 1965 Dec;150(3):463–468. [PubMed] [Google Scholar]
  3. BROWN B. T., RANGER D., WRIGHT S. E. The excretory products of lanatoside C and digitoxin in the rat. J Pharmacol Exp Ther. 1955 Mar;113(3):353–358. [PubMed] [Google Scholar]
  4. Berg J. W., Kolenda K. D., Peters T., Seiler K. U. Metodik der Perfusion isolierter Meerschweinchenlebern. Arztl Forsch. 1970 Aug 10;24(8):240–244. [PubMed] [Google Scholar]
  5. Doherty J. E. The clinical pharmacology of digitalis glycosides: a review. Am J Med Sci. 1968 Jun;255:382–414. doi: 10.1097/00000441-196806000-00006. [DOI] [PubMed] [Google Scholar]
  6. Domschke W., Meinecke O., Domagk G. F. Untersuchungen zum Stoffwechsel des Digitaliszuckers Digitoxose in der Ratte. Naunyn Schmiedebergs Arch Pharmakol. 1969;265(2):149–155. [PubMed] [Google Scholar]
  7. Förster W., Grade K. The uptake and content of digitoxin and its metabolites in the heart muscle of rats and guinea-pigs after acute and chronic application. Biochem Pharmacol. 1967 Jul 7;16(7):1165–1174. doi: 10.1016/0006-2952(67)90148-7. [DOI] [PubMed] [Google Scholar]
  8. GONZALEZ L. F., LAYNE E. C. Studies on tritum-labeled digoxin: tissue, blood and urine determinations. J Clin Invest. 1960 Oct;39:1578–1583. doi: 10.1172/JCI104179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gadke J., van Zwieten P. A. Vergleichende Untersuchungen am Meerschweinchen über die Serum-radioaktivität, die Ausscheidung und die Gewebsverteilung von 3H-Digitoxin und 3H-Digitoxigenin. Naunyn Schmiedebergs Arch Pharmakol. 1969;264(3):234–235. [PubMed] [Google Scholar]
  10. Griffin C. L., Burstein S. H. Metabolism of cardiac glycosides. I. Metabolism of digitoxin-7-alpha-T by normal rabbits and rabbits with heart failure. Biochem Pharmacol. 1967 Mar;16(3):447–454. doi: 10.1016/0006-2952(67)90092-5. [DOI] [PubMed] [Google Scholar]
  11. HERRMANN I., REPKE K. ENTGIFTUNGSGESCHWINDIGKEIT UND KUMULATION VON DIGITOXIN BEI VERSCHIEDENEN SPECIES. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 Apr 9;247:19–34. doi: 10.1007/BF00246339. [DOI] [PubMed] [Google Scholar]
  12. HERRMANN I., REPKE K. KONJUGATION VON CARDENOLIDGENINEN MIT SCHWEFELSAEURE ODER GLUCURONSAEURE. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 Jun 22;248:370–386. [PubMed] [Google Scholar]
  13. HERRMANN I., REPKE K. SPECIESUNTERSCHIEDE IN DER BIOTRANSFORMATION VON DIGITOXIN. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 Apr 9;247:35–48. doi: 10.1007/BF00246340. [DOI] [PubMed] [Google Scholar]
  14. Katzung B. G., Meyers F. H. Biotransformation of digitoxin in the dog. J Pharmacol Exp Ther. 1966 Dec;154(3):575–580. [PubMed] [Google Scholar]
  15. Katzung B. G., Meyers F. H. Excretion of radioactive digitoxin by the dog. J Pharmacol Exp Ther. 1965 Aug;149(2):257–262. [PubMed] [Google Scholar]
  16. Kolenda K. D., Lüllmann H., Peters T., Seiler K. U. Plasma concentration, uptake by liver, and biliary excretion of tritiated cardiac glycosides in the isolated perfused guinea-pig liver. Br J Pharmacol. 1971 Apr;41(4):648–660. doi: 10.1111/j.1476-5381.1971.tb07073.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kuschinsky K. Uber die Bindungseigenschaften von Plasmaproteinen für Herzglykoside. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1969;262(3):388–398. [PubMed] [Google Scholar]
  18. LAUTERBACH F., REPKE K., NITZ D. [The enzymatic decomposition of D-digitoxose, D-cymarose and L-thevetose from cardiac glycosides by liver sections]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1960;239:196–218. [PubMed] [Google Scholar]
  19. Lage G. L., Spratt J. L. H3-digoxin metabolism by adult male rat tissues in vitro. J Pharmacol Exp Ther. 1965 Aug;149(2):248–256. [PubMed] [Google Scholar]
  20. Lage G. L., Spratt J. L. Species and sex variation in the hepatic metabolism of H3-digoxin in vitro. J Pharmacol Exp Ther. 1968 Jan;159(1):182–193. [PubMed] [Google Scholar]
  21. Lüllmann H., Peters T., van Zwieten P. A. The distribution of 3H-labelled cardenolides between isolated guinea-pig atrial tissue and circulating, oxygenated whole blood. Br J Pharmacol. 1969 Jun;36(2):276–285. doi: 10.1111/j.1476-5381.1969.tb09505.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. MARCUS F. I., KAPADIA G. J., KAPADIA G. G. THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS. J Pharmacol Exp Ther. 1964 Aug;145:203–209. [PubMed] [Google Scholar]
  23. MARKS B. H., DUTTA S., GAUTHIER J., ELLIOTT D. DISTRIBUTION IN PLASMA, UPTAKE BY THE HEART AND EXCRETION OF OUABAIN-H3 IN HUMAN SUBJECTS. J Pharmacol Exp Ther. 1964 Sep;145:351–356. [PubMed] [Google Scholar]
  24. Marcus F. I., Burkhalter L., Cuccia C., Pavlovich J., Kapadia G. G. Administration of tritiated digoxin with and without a loading dose. A metabolic study. Circulation. 1966 Nov;34(5):865–874. doi: 10.1161/01.cir.34.5.865. [DOI] [PubMed] [Google Scholar]
  25. OKITA G. T., TALSO P. J., CURRY J. H., Jr, SMITH F. D., Jr, GEILING E. M. Metabolic fate of radioactive digitoxin in human subjects. J Pharmacol Exp Ther. 1955 Dec;115(4):371–379. [PubMed] [Google Scholar]
  26. REPKE K., KLESCZEWSKI S., ROTH L. [On splitting and hydroxylation of digitoxin in the rat]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1959;237:34–48. [PubMed] [Google Scholar]
  27. REPKE K. [The bis- and mono-digitoxosides of digitoxigenin and digoxigenin: metabolites of digitoxin]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1959;237:155–170. [PubMed] [Google Scholar]
  28. Repke K. Biochemie und Klinik der Digitalis. Internist (Berl) 1966 Aug;7(8):418–426. [PubMed] [Google Scholar]
  29. Ruiz-Torres A. Kinetik der Herzteroide im Organismus des Menschen und der Versuchstiere. Klin Wochenschr. 1970 Mar 1;48(5):257–270. doi: 10.1007/BF01486434. [DOI] [PubMed] [Google Scholar]
  30. Scholtan W. Die hydrophobe bindung der Pharmaka an Humanalbumin und Ribonucleinsäure. Arzneimittelforschung. 1968 May;18(5):505–517. [PubMed] [Google Scholar]
  31. Scholtan W., Schlossmann K., Rosenkranz H. Bestimmung der Eiweissbindung von Digitalis-Präparaten mittels der Ultrazentrifuge. Arzneimittelforschung. 1966 Feb;16(2):109–118. [PubMed] [Google Scholar]
  32. Seipel H., Hueber E. F., Deutsch E., Lutz U., Wichtl M., Jentzsch K. Quantitative Digitoxinbestimmung im Blut routinemässig digitalisierter Patienten. Klin Wochenschr. 1968 Dec 1;46(23):1257–1260. doi: 10.1007/BF01711869. [DOI] [PubMed] [Google Scholar]
  33. WONG K. C., SPRATT J. L. Assay of radioactive digoxin in liver tissue. Biochem Pharmacol. 1963 Jun;12:577–579. doi: 10.1016/0006-2952(63)90133-3. [DOI] [PubMed] [Google Scholar]
  34. Wilson W. S. Metabolism of digitalis. Prog Cardiovasc Dis. 1969 May;11(6):479–487. doi: 10.1016/0033-0620(69)90002-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES